These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Shopsin B; Gershon S; Thompson H; Collins P Arch Gen Psychiatry; 1975 Jan; 32(1):34-42. PubMed ID: 1089401 [TBL] [Abstract][Full Text] [Related]
25. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204 [TBL] [Abstract][Full Text] [Related]
26. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Reschke RW Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080 [TBL] [Abstract][Full Text] [Related]
27. A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda. Lubinga SJ; Mutamba BB; Nganizi A; Babigumira JB Appl Health Econ Health Policy; 2015 Oct; 13(5):493-506. PubMed ID: 25958192 [TBL] [Abstract][Full Text] [Related]
28. [On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia]. Zolotnitskii RI; Kutsenok BM; Gastev MD Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(5):750-4. PubMed ID: 5363890 [No Abstract] [Full Text] [Related]
29. Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period. Ravanic DB; Dejanovic SM; Janjic V; Jovic SD; Milovanovic DR; Jakovljevic V; Pantovic V; Ravanic B; Pantovic M; Pantovic MM Arq Neuropsiquiatr; 2009 Jun; 67(2A):195-202. PubMed ID: 19547808 [TBL] [Abstract][Full Text] [Related]
30. Effects of antipsychotic drugs on memory functions of schizophrenic patients. Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670 [TBL] [Abstract][Full Text] [Related]
31. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics. Rompel H; Segal H J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086 [TBL] [Abstract][Full Text] [Related]
32. Action of chlorpromazine on the vagal cardio-inhibitory center. DE VLEESCHHOUWER GR; KING TO; POULSEN E; ROVATI AL Arch Int Pharmacodyn Ther; 1957 Nov; 112(3-4):485-90. PubMed ID: 13498873 [No Abstract] [Full Text] [Related]
33. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action. Gallant DM; Bishop M; Guerrero-Figueroa R Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981 [No Abstract] [Full Text] [Related]
34. Drug-induced dystonia. Swett C Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613 [TBL] [Abstract][Full Text] [Related]
35. Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved. Koga M; Nakayama K Acta Psychiatr Scand; 2005 Jul; 112(1):75-6; discussion 77. PubMed ID: 15952949 [TBL] [Abstract][Full Text] [Related]
36. The effects of pharmacological manipulations that influence vagal control of the heart on heart period, heart-period variability and respiration in rats. Yongue BG; McCabe PM; Porges SW; Rivera M; Kelley SL; Ackles PK Psychophysiology; 1982 Jul; 19(4):426-32. PubMed ID: 7122781 [No Abstract] [Full Text] [Related]
37. Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine. Man PL; Chen CH Psychosomatics; 1973; 14(1):59-63. PubMed ID: 4605009 [No Abstract] [Full Text] [Related]
38. [Studies on the pupillary reaction in the course of a psychotropic treatment]. Popkowska N Neurol Neurochir Psychiatr Pol; 1966 Feb; 16(2):167-71. PubMed ID: 5913352 [No Abstract] [Full Text] [Related]
39. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients. Ishizaki T; Chiba K; Saito M; Kobayashi K; Iizuka R J Clin Psychopharmacol; 1984 Oct; 4(5):254-61. PubMed ID: 6149238 [TBL] [Abstract][Full Text] [Related]
40. Effects of L-DOPA on pharmacological parkinsonism. Bruno A; Bruno SC Acta Psychiatr Scand; 1966; 42(3):264-71. PubMed ID: 5335155 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]